Abstract
Dynamic contrast-enhanced (DCE) MRI is often used to measure the transfer constant (Ktrans) and distribution volume (ve) in pelvic tumors. For optimal accuracy and reproducibility, one must quantify the arterial input function (AIF). Unfortunately, this is challenging due to inflow and signal saturation. A potential solution is to use MR signal phase (ϕ), which is relatively unaffected by these factors. We hypothesized that phase-derived AIFs (AIFϕ) would provide more reproducible Ktrans and ve values than magnitude-derived AIFs (AIF|S|). We tested this in 27 prostate dynamic contrast-enhanced MRI studies (echo time = 2.56 ms, temporal resolution = 13.5 s), using muscle as a standard. AIFϕ peak amplitude varied much less as a function of measurement location (inferior–superior) than AIF|S| (5.6 ± 0.6 mM vs. 2.6 ± 1.5 mM), likely as a result of ϕ inflow insensitivity. However, our main hypothesis was not confirmed. The best AIF|S| provided similar reproducibility versus AIFϕ (interpatient muscle Ktrans = 0.039 ± 0.021 min−1 vs. 0.037 ± 0.025 min−1, ve = 0.090 ± 0.041 vs. 0.062 ± 0.022, respectively).
Keywords: magnetic resonance imaging, arterial input function, dynamic contrast-enhanced MRI, MR signal phase
Dynamic contrast-enhanced MRI (DCE-MRI) involves rapid, continuous imaging during and after the administration of a gadolinium (Gd)-based contrast agent (GdCA). The time series of images is analyzed to obtain physiological information about the microvasculature of the tissue such as Ktrans, the volume transfer constant for exchange between blood plasma and the extravascular extracellular space, and ve, the volume of the extravascular extracellular space per unit volume of tissue (1,2). This dynamic technique has many applications in the human pelvis, most importantly in characterizing tumors. DCE-MRI has been used for tumor staging, prediction of outcome, and detection of recurrence (3–7), as well as monitoring the response of tumors to treatment (8–10).
To maximize DCE-MRI accuracy and reproducibility, absolute quantification of GdCA concentration vs. time in tissue and arterial blood (arterial input function or AIF) is necessary (11–14). Unfortunately, as in other body regions, quantification of the AIF in the pelvis (using the aorta, iliac, or femoral arteries) is challenging due to saturation, inflow and nonuniformity of the B1 field of the radiofrequency pulses across the volume of interest (2,12,13,15–19). Often the AIF is found to be so difficult to measure that a population-averaged AIF is used instead (1,3,7,8,10).
A potential solution for the AIF problem is the use of MR signal phase (ϕ), which is normally discarded once the magnitude MR images are reconstructed. ϕ is linear with GdCA concentration (i.e., no saturation), is less sensitive to B1 variations, and can provide absolute measures of GdCA concentration (12,13,15–17). Moreover, ϕ is relatively unaffected by inflow, due to the fact that ϕ in blood is not biased by the inflow-related increase in the MR signal magnitude (|S|) (12). Furthermore, ϕ can be obtained from any gradient-echo-based DCE-MRI pulse sequence, without the need for additional measurements or specialized pulse sequences.
In this work, ϕ was saved for 27 routine prostate DCE-MRI exams. Using obturator internus muscle (OIM) as a reference (i.e., assuming that this muscle has the same Ktrans and ve values in all of our subjects), we hypothesized that individually measured phase-derived AIFs (AIFϕ) would provide more reproducible Ktrans and ve values than individually measured magnitude-derived AIFs (AIF|S|).
MATERIALS AND METHODS
Imaging was performed on a 1.5 T Siemens Symphony MR scanner using a whole-body transmit coil with whole-body, “flex,” and spine receive coils. Conventional magnitude image data as well as raw data were saved from 27 DCE-MRI studies performed during routine, clinical, Gd-enhanced prostate examinations. DCE was performed using a 3D spoiled gradient echo sequence with TR = 5.8 ms, flip angle = 35°, echo time (TE) = 2.56 ms, 20 5-mm-thick axial slices, field of view = 250 × 220 mm2, matrix = 256 × 224, temporal resolution = 13.5 s, total number of 3D data sets (number of time points) = 30, total acquisition time = 6.75 min. The CA was Gadovist® (Berlex, Inc., Canada) and 0.2 mmol per kg of body weight was injected intravenously via a power injector at a rate of 4 mL/s (followed by a saline flush) after four baseline time points were acquired. The double dose (0.2 mmol/kg) was used to obtain greater signal enhancement in tissue, to maximize tumor detection. Image analysis was performed offline using custom software written in IDL© (ITT Visual Information Solutions) to reconstruct the raw data and manipulate images.
For each patient, three contiguous slices were identified which encompassed the largest cross-section of OIM. On each of these three slices, an 86 mm2 region of interest (ROI) was drawn on both left and right OIM. For each 3D image set (i.e. each time point), the magnitude signal of OIM was calculated as the average signal in all six of these ROIs (left and right × 3 slices). Circular ROIs were also drawn in the lumen of either the external iliac or femoral arteries in each of the 20 slices.
The OIM magnitude signal as a function of time, |S| (t), was converted to T1 vs. time via standard spoiled gradient echo equations (20,21). The native (pre-GdCA) T1(T1,0) in muscle was assumed to be 1000 ms (20). GdCA concentration vs. time in OIM was computed from changes in 1/T1 assuming a T1 relaxivity of 4.3 mM−1 s−1. Tracer, kinetic modeling was performed on the OIM concentration vs. time curve to obtain Ktrans and ve, using the theory of Kety, assuming fast water exchange between all compartments (intra/extravascular, intra/extracellular), a negligible plasma compartment, and hematocrit of 0.45 (2).
For each patient, Ktrans and ve were computed in four separate analyses, with each analysis differing only in the AIF used. These four different AIFs were: (1) AIFTK, a population-averaged AIF (i.e., identical AIF to be used for all 27 patients) developed in the early 1990s by Tofts and Kermode (22). This AIF is in the form of a biexponential decay which was fit to the data of Weinmann et al. (23) and has been used by a large number of researchers. (2) AIFP, a high temporal resolution population-averaged AIF recently developed by Parker et Al. (1). Both AIFTK and AIFP were scaled to reflect the correct injection dose of 0.2 mmol/kg. (3) AIF|S|, an MR signal magnitude-derived AIF. (4) AIFϕ, an MR signal phase-derived AIF. AIF|S| and AIFϕ were calculated separately for each subject (calculation details given below).
For the calculation of AIF|S|, |S| (t) data from the arterial ROI voxels (external iliac or femoral arteries) were averaged together for blocks of five contiguous slices. The slice blocks used were overlapped to form a total of seven slice blocks. For comparison purposes, the relative position of the center of each block (inferior–superior direction) was varied from 0.125 to 0.875, where zero represents the most inferior edge of the entire 3D block and one represents the most superior edge. The average |S| (t) was then converted to whole-blood GdCA concentration vs. time (Ca(t)) using the same procedure as for the OIM, assuming blood T1,0 = 1250 ms (19).
AIFϕ was calculated in a similar way except that changes in ϕ(t) relative to the baseline phase ϕ0 [i.e., Δϕ(t) = ϕ(t) = ϕ0] were used. When necessary, “unwrapping” of Δϕ(t) was used to keep the ϕ difference for successive points between ±π radians (15,24). Voxels were rejected if there was a shape mismatch between the |S| (t) and Δϕ(t) curves, as determined by the cross-correlation following the work of van Osch et al. (24). The cross-correlation can range from −1 to +1, with a value of +1 meaning that both curves have identical shapes. A threshold value of +0.1 was determined empirically after testing values ranging from 0.0 to 1.0 in increments of 0.1, where it was found that all values above zero resulted in similar AIFs. Voxels were also rejected if Δϕ(t) exhibited a positive, instead of the expected negative, slope during the last 4.5 min of the curve (24). The average Δϕ(t) was converted to Ca(t) using the following equation (12,14,17,24):
[1] |
where γ is the proton gyromagnetic ratio (4.258 × 107 Hz/T), B0 is the magnitude of the main magnetic field in Tesla, χm is the molar susceptibility of the CA (3.4 × 10−7 mM−1 for Gd, in MKS units), and θ is the angle of the vessel relative to the main magnetic field (θ = 0° being parallel with that field). θ was set to an average value of 15°, based on the observed orientations of the arteries (15° ± 6° for all 27 patients). An additional AIFϕ was also calculated using all 20 slices instead of just one block of five slices (rationale given in Results section).
These calculations resulted in four sets of Ktrans and ve distributions (one set per AIF type). For each distribution, outliers were defined as points lying more than five standard deviations away from the mean of the remaining distribution and were removed. Reproducibility of the distributions was measured using the coefficient of variation (COV), defined as the standard deviation divided by the mean, expressed as a percent. Reproducibility is inversely related to COV, assuming that Ktrans and ve in OIM are the same for all patients.
For each block of five contiguous slices used to compute the AIFs, the AIF curves and resulting Ktrans and ve parameters were each averaged (and standard deviations computed) over all 27 patients, to investigate dependencies on slice position (inferior–superior). The variation of the AIF|S| and AIFϕ amplitudes with slice position were compared via the F test of equality of two variances. The variation of Ktrans and ve with slice position was analyzed using a one-way ANOVA. The Ktrans and ve values computed from the four AIFs tested in this work were compared via the Student’s t test (to compare means) and the F test of equality of two variances (to compare COVs).
For each of AIF|S| and AIFϕ, the interpatient mean, standard deviation, and COV of the maximum amplitude, equilibrium amplitude (mean of last 1 min), and area under the curve were measured. To compare AIF|S| and AIFϕ for these characteristics, the Student’s t test was used to compare means and the F test of equality of two variances was used to compare COVs.
Tracer kinetic parameters were also measured in right versus left OIM, to check for any systematic differences between the two. All calculations were repeated with T1,0 for OIM = 850 and 1150 ms, to test the sensitivity of the results to the T1,0 used.
RESULTS
The measured GdCA concentration vs. time in OIM, averaged over all 27 patients, exhibited a plateau of 0.15 ± 0.05 mmol/kg (Fig. 1).
AIF|S| varied significantly with measurement position, with decreasing amplitude towards the superior slices. The peak amplitude of these AIFs ranged from 0.5 to 4.3 mM, whereas the washout amplitude (defined as the average of the last 1 min of data) ranged from 0.2 to 1.0 mM (Fig. 2a). For AIFϕ, the peak and washout amplitudes ranged from 4.7 to 6.7 mM and from 1.3 to 2.2 mM, respectively, (Fig. 2b). The AIFϕ’s peak amplitudes varied considerably less with measurement position than that of AIF|S| (F test, P < 0.001).
For AIF|S|, Ktrans and ve both varied significantly with the position used to measure the AIF. Interpatient mean values of Ktrans ranged from 0.039 to 0.263 min−1, whereas those for ve ranged from 0.090 to 0.373 (Fig. 3). Both Ktrans and ve varied smoothly with the position used to measure the AIF, reaching minimum values at a relative position (defined in Methods section) of 0.25. For all further analyses employing AIF|S|, it was assumed that the most accurate AIF measurements would be found at the relative position of 0.25, where both inflow and slab profile effects are presumably minimal (25). Thus, the artery data at that position only were used for further analyses involving AIF|S| (i.e., Fig. 4 and Table 1).
Table 1.
Study | AIF |
Ktrans (min−1)
|
ve (unitless)
|
||||
---|---|---|---|---|---|---|---|
Mean | SD | COVa | Mean | SD | COVa | ||
Currentb | Tofts/Kermode | 0.137 | 0.085 | 62 | 0.118 | 0.031 | 26 |
Current | Parker | 0.022 | 0.009 | 41 | 0.087 | 0.027 | 31 |
Current | |S| | 0.039 | 0.021 | 54 | 0.090 | 0.041 | 46 |
Current | ϕ | 0.037 | 0.025 | 68 | 0.062 | 0.022 | 35 |
Padhani et al.c | Tofts/Kermode | 0.156 | 0.095 | 61 | 0.113 | 0.021 | 19 |
Buckley et al.b | |S| | 0.045 | 0.025 | 56 | 0.130 | 0.040 | 31 |
Yankeelov et al.d | Blood samplinge | 0.021 | 0.002 | 10 | 0.067 | 0.010 | 15 |
For AIFϕ, interpatient mean values of Ktrans did not vary significantly as a function of the position used for the AIF (one-way ANOVA, F = 0.89, P = 0.5). The interpatient mean values of ve did vary significantly with the position used to measure the AIF (range 0.043–0.076), although this variation was much less than that for AIF|S| (range 0.090–0.373). However, for relative positions >0.25, ve values obtained using AIFϕ did not show a statistically significant dependence on the position used to measure the AIF (one-way ANOVA, F = 1.7, P = 0.15). As a result of this generally small dependence on slice position, all further analyses employing AIFϕ were performed with AIFs measured using all slice positions (i.e., Fig. 4 and Table 1).
The general effect of switching from one AIF to another was a statistically significant change in the mean of the Ktrans or ve distributions with no significant change in reproducibility (COV) (Fig. 4, Table 1). However, there were some exceptions to this general trend: the mean Ktrans was the same for AIF|S| and AIFϕ (Student’s t test, P = 0.7); the mean ve was the same for AIFP and AIF|S| (Student’s t test, P = 0.8); AIFP provided better Ktrans reproducibility than AIFTK (F test, P = 0.02) and AIFϕ (F test, P = 0.006); finally, AIFTK provided better ve reproducibility than AIF|S| (F test, P = 0.008).
For the Ktrans and ve distributions measured in this study, outliers were rare (typically zero or one per 27 patients, maximum of three). Moreover, no statistically significant difference in enhancement or tracer kinetic parameters was observed between right and left OIM. T1,0 for OIM had no major effect on the relationships between the different Ktrans and ve distributions. On average, 12% of the pixels in the AIF ROIs were rejected for having a cross-correlation between |S|(t) and Δϕ(t) of less than 0.1, and 24% of the pixels in the AIF ROIs were rejected for having a positive slope in Δϕ(t) during the last 4.5 min.
For the optimal AIF|S|, computed for relative slice position 0.25, the interpatient maximum amplitude, equilibrium amplitude (mean of last 1 min), and area under the curve were 4.1 ± 1.3 mM (COV = 32%), 1.0 ± 0.27 mM (COV = 27%), and 460 ± 115 mM s (COV = 25%), respectively. For AIFϕ, the interpatient maximum amplitude, equilibrium amplitude, and area under the curve were 5.7 ± 2.4 mM (COV = 41%), 1.4 ± 0.56 mM (COV = 39%), and 620 ± 140 mM (COV = 23%), respectively. The mean values of maximum and equilibrium amplitude were significantly different for AIF|S| and AIFϕ (Student’s t test, P ≤ 0.001). COVs were not significantly different; however, except for equilibrium amplitude which was nearly significant (F test, P = 0.051). The intrapatient COVs for AIF|S| averaged over all slice positions were much higher than those reported above.
DISCUSSION
In this work, phase-derived AIFs (AIFϕ) were compared with magnitude-derived AIFs (AIF|S|) for 27 routine prostate DCE-MRI exams, with the hypothesis that the AIFϕs would provide more reproducible Ktrans and ve values in OIM. It is important to note that the AIFϕ’s are available “for free”, requiring only that one save the raw data from any gradient-echo pulse sequence used for DCE-MRI. No additional image acquisitions or specialized pulse sequences are necessary.
AIFϕ varied much less in amplitude as a function of measurement location (inferior–superior) than AIF|S|. This result is not surprising, given that ϕ is much less sensitive to inflow effects. Measuring the AIF with ϕ can therefore potentially offer more flexibility in terms of where the AIF may be sampled.
Ktrans and ve values determined using the AIF|S|’s exhibited a strong, undesirable dependence on AIF measurement position. However, with the particular imaging protocol used in this work, and with the AIF|S| measured at its optimal position (halfway between the center slice of the 3D slab and the most inferior slice), AIFϕ, averaged over all slices, provided approximately equal, although not improved, reproducibility in Ktrans and ve compared to AIF|S| and population-averaged AIFs. This may be due to the relatively poor temporal resolution (13.5 s) and short, single TE (2.56 ms) of the DCE MRI pulse sequence used (13,21). We have shown previously that, for temporal resolution = 2.2 s and TE = 5.5 ms, both the accuracy and precision of vascular function measurements in the brain are significantly improved by using ϕ (26). Further work is thus needed to evaluate whether improved temporal resolution and longer TE could provide an overall precision advantage using ϕ for pelvic AIFs. For a fixed temporal resolution, given that Δϕ does not saturate with GdCA concentration, the signal-to-noise ratio (SNR) for AIFϕ is expected to be proportional to TE and to the dose of GdCA used. One possibility for improving AIFϕ would therefore be simply to employ a double-echo pulse sequence where the second, longer TE would provide more phase accrual and therefore increased phase SNR (13). It also follows that using a standard GdCA dose (0.1 mmol/kg) instead of a double dose (0.2 mmol/kg) would be expected to worsen the SNR for AIFϕ by a factor of two, unless the TE was doubled. On the other hand, |S| begins to experience saturation effects for GdCA >2–3 mM; therefore, using a standard GdCA dose instead of a double dose would be expected to reduce saturation effects in |S| and improve AIF|S| measurements. Using a standard GdCA dose would decrease GdCA enhancement in tissue, however, which would reduce the overall precision of the tracer kinetic parameters. One advantage of using AIFϕ is that double GdCA doses can be used to improve tissue enhancement, without saturating the AIF measurements.
The choice of AIF type strongly affected the mean Ktrans and ve values in OIM. This shows that interinstitution comparisons of Ktrans and ve values may be difficult without careful consideration of the AIF techniques used to measure the AIF. The results reported here and elsewhere show that the Tofts and Kermode population AIF produces Ktrans values which are much greater than those produced by the other AIFs (see Fig. 4 and Table 1). This is due to the fact that AIFTK does not have sufficient temporal resolution to represent accurately the rapid first pass of GdCA, resulting in a peak amplitude which is at least four times smaller than those of the other AIFs, ultimately leading to much larger Ktrans values. It should also be noted that the choice of AIF type affected ve (mean values ranging from 0.062 to 0.118) much less than Ktrans (mean values ranging from 0.037 to 0.137 min−1), which is consistent with the literature (11).
The average estimated GdCA concentration vs. time in OIM, averaged over all 27 patients, was consistent with the results of Padhani et al. (8), who reported a maximum GdCA accumulation in the left OIM of 0.086 ± 0.020 mmol/kg for a GdCA dose of 0.1 mmol/kg of body weight.
The decrease in the calculated AIF|S| amplitude toward superior slices (Fig. 2) may be attributed to reduced GdCA contrast in arterial blood of superior slices due to inflow, as has been observed by other investigators (25,27). This effect was not seen with AIFϕ
For the equilibrium portion of the AIF curves (Fig. 2, time > 2 min), AIFϕ showed about the same spread in values compared to AIF|S|. This is likely, in part, because the magnitude curves are less error-prone for that part of the AIF than they are at the peak. The equilibrium portion involves much lower GdCA concentrations, resulting in reduced errors in the magnitude signal due to saturation. For this portion, the AIFϕ were also significantly noiser (in time) than the AIF|S|. This is not surprising, given that the ratio of phase SNR to magnitude SNR is approximately equal to the phase angle in radians (28): for this work, the phase angle on the equilibrium portion of the AIF curve (relative to baseline) was only about 0.13 radians. The amplitudes of the equilibrium portion of AIFϕ also appear to have a small dependence on slice position, although the reasons for this are not clear.
The values of Ktrans and ve calculated for this study using AIFTK were consistent with those found by Padhani et al. (8), who also used AIFTK (Fig. 4, Table 1). The values of Ktrans calculated for this study using the other three AIFs (Parker, |S|, ϕ) were more consistent with Ktrans values found in recent studies performed by Buckley et al. (20) and Yankeelov et al. (2). The similarity of Ktrans values between the current study, the Buckley study, and the Yankeelov study is not surprising, considering that the Buckley and Yankeelov studies employed high-temporal resolution (1.5–2.5 s) individually measured AIFs similar in amplitude to those of the Parker, |S|, and ϕ AIFs of this study. The values of ve calculated for this study using the Parker, |S|, and ϕ AIFs tended to lie between those found by Padhani and Yankeelov.
The study reported here had several limitations. T1,0 was not measured in blood, which may have adversely affected the reproducibility of AIF|S| and the values of Ktrans and ve computed from it. T1,0 was also not measured in OIM. Although this will have affected the Ktrans and ve measurements, it has no fundamental impact on the comparison between results obtained from AIF|S| and AIFϕ. This work assumed that all patients have the same Ktrans and ve values in OIM. True variations between patients would, therefore, worsen the observed measurement precision and could potentially mask any differences in fundamental measurement precision between the analyses performed with AIF|S| and AIFϕ. Correction for blood vessel orientation (θ in Eq. 1) was not performed for each patient, although the relatively small variation of observed angles (standard deviation = 6°) indicates that this should not have affected the AIFϕ’s by more than 10%. The temporal resolution used in this particular study (13.5 s) was not sufficient to achieve complete characterization of the first pass peak of the AIF (29). Such undersampling can introduce large errors into the tracer kinetic parameters. For a temporal resolution of 13.5 s, simulations reported by Roberts et al. indicate that Ktrans may suffer errors in the range of 15–60% due to undersampling of the AIF (29).
CONCLUSION
For quantitative DCE-MRI of the human pelvis performed using a 3D spoiled gradient echo pulse sequence with a single short TE (2.56 ms) and modest temporal resolution (13.5 s), MR signal phase-derived AIFs measured in the external iliac or femoral arteries vary much less in amplitude, as a function of measurement location (inferior–superior), than magnitude-derived AIFs. This is likely due to the fact that phase is much less sensitive to inflow effects than magnitude. The phase-derived AIFs did not, however, improve reproducibility in Ktrans and ve measured in OIM compared to “optimal” magnitude-derived and population-averaged AIFs. Thus, although the phase technique shows promise, further work using improved acquisition protocols is warranted.
Acknowledgments
Grant sponsor: Ontario Graduate Scholarship program; Grant sponsor: Kiwanis Club of Ottawa Medical Foundation and Dr. Kanta Marwah; Grant sponsor: NIH; Grant number: 1K25 AQ9 EB005936 (Career Development award via NIBIB).
Funding for C.F. was provided by the Ontario Graduate Scholarship program, the Kiwanis Club of Ottawa Medical Foundation, and Dr. Kanta Marwah. T.E.Y. is partially supported by a Career Development award from NIH via NIBIB.
References
- 1.Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med. 2006;56:993–1000. doi: 10.1002/mrm.21066. [DOI] [PubMed] [Google Scholar]
- 2.Yankeelov TE, Cron GO, Addison CL, Wallace JC, Wilkins RC, Pappas BA, Santyr GE, Gore JC. Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data. Magn Reson Med. 2007;57:353–361. doi: 10.1002/mrm.21131. [DOI] [PubMed] [Google Scholar]
- 3.Jackson AS, Reinsberg SA, Sohaib SA, Charles-Edwards EM, Jhavar S, Christmas TJ, Thompson AC, Bailey MJ, Corbishley CM, Fisher C, Leach MO, Dearnaley DP. Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol. 2009;82:148–156. doi: 10.1259/bjr/89518905. [DOI] [PubMed] [Google Scholar]
- 4.Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol. 2007;8:245–255. doi: 10.1016/S1470-2045(07)70075-X. [DOI] [PubMed] [Google Scholar]
- 5.Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007;63:335–350. doi: 10.1016/j.ejrad.2007.06.028. [DOI] [PubMed] [Google Scholar]
- 6.Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology. 2003;229:248–254. doi: 10.1148/radiol.2291020200. [DOI] [PubMed] [Google Scholar]
- 7.Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med. 2005;53:249–255. doi: 10.1002/mrm.20374. [DOI] [PubMed] [Google Scholar]
- 8.Padhani AR, Hayes C, Landau S, Leach MO. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed. 2002;15:143–153. doi: 10.1002/nbm.732. [DOI] [PubMed] [Google Scholar]
- 9.Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63–74. doi: 10.1016/S1470-2045(06)71012-9. [DOI] [PubMed] [Google Scholar]
- 10.Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, Brenton JD, Lomas DJ, Sala E. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys. 2009;74:766–773. doi: 10.1016/j.ijrobp.2008.08.023. [DOI] [PubMed] [Google Scholar]
- 11.Cheng HL. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2008;28:736–743. doi: 10.1002/jmri.21489. [DOI] [PubMed] [Google Scholar]
- 12.de Rochefort L, Nguyen T, Brown R, Spincemaille P, Choi G, Weinsaft J, Prince MR, Wang Y. In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med Phys. 2008;35:5328–5339. doi: 10.1118/1.3002309. [DOI] [PubMed] [Google Scholar]
- 13.Foottit C, Cron GO, Hogan MJ, Nguyen TB, Cameron I. Determination of the venous output function from MR signal phase: Feasibility for quantitative DCE-MRI in human brain. Magn Reson Med. 2010;63:772–781. doi: 10.1002/mrm.22253. [DOI] [PubMed] [Google Scholar]
- 14.Duhamel G, Schlaug G, Alsop DC. Measurement of arterial input functions for dynamic susceptibility contrast magnetic resonance imaging using echoplanar images: comparison of physical simulations with in vivo results. Magn Reson Med. 2006;55:514–523. doi: 10.1002/mrm.20802. [DOI] [PubMed] [Google Scholar]
- 15.Kotys MS, Akbudak E, Markham J, Conturo TE. Precision, signal-to-noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI. J Magn Reson Imaging. 2007;25:598–611. doi: 10.1002/jmri.20859. [DOI] [PubMed] [Google Scholar]
- 16.Cron GO, Wallace JC, Stevens WD, Fortin T, Pappas BA, Wilkins RC, Kelcz F, Santyr GE. A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent. Magn Reson Imaging. 2005;23:619–627. doi: 10.1016/j.mri.2005.02.016. [DOI] [PubMed] [Google Scholar]
- 17.van Osch MJ, Vonken EJ, Viergever MA, van der Grond J, Bakker CJ. Measuring the arterial input function with gradient echo sequences. Magn Reson Med. 2003;49:1067–1076. doi: 10.1002/mrm.10461. [DOI] [PubMed] [Google Scholar]
- 18.Ishida M, Sakuma H, Murashima S, Nishida J, Senga M, Kobayasi S, Takeda K, Kato N. Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data. J Magn Reson Imaging. 2009;29:205–210. doi: 10.1002/jmri.21470. [DOI] [PubMed] [Google Scholar]
- 19.Cheng HL. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging. 2007;25:1073–1078. doi: 10.1002/jmri.20898. [DOI] [PubMed] [Google Scholar]
- 20.Buckley DL, Kershaw LE, Stanisz GJ. Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle. Magn Reson Med. 2008;60:1011–1019. doi: 10.1002/mrm.21748. [DOI] [PubMed] [Google Scholar]
- 21.McGrath DM, Bradley DP, Tessier JL, Lacey T, Taylor CJ, Parker GJ. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats. Magn Reson Med. 2009;61:1173–1184. doi: 10.1002/mrm.21959. [DOI] [PubMed] [Google Scholar]
- 22.Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17:357–367. doi: 10.1002/mrm.1910170208. [DOI] [PubMed] [Google Scholar]
- 23.Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR. 1984;16:167–172. [PubMed] [Google Scholar]
- 24.van Osch MJ, Vonken EJ, Bakker CJ, Viergever MA. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med. 2001;45:477–485. doi: 10.1002/1522-2594(200103)45:3<477::aid-mrm1063>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- 25.Roberts C, Buckley DL, Parker GJ. To assume or not to assume blood T1 for AIF measurement in DCE-MRI?. Proceedings of the 17th Annual Meeting of ISMRM; Honolulu, Hawaii. 2009. p. 2278. [Google Scholar]
- 26.Foottit C, Cron GO, Nguyen TB, Hogan MJ, Cameron I. Improved venous output function using MR signal phase for quantitative 2D DCE-MRI in human brain. Proceedings of the 18th Annual Meeting of ISMRM; Stockholm. 2010. p. 1719. [Google Scholar]
- 27.Zhang JL, Rusinek H, Bokacheva L, Chen Q, Storey P, Lee VS. Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2009;30:656–665. doi: 10.1002/jmri.21891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med. 1995;34:910–914. doi: 10.1002/mrm.1910340618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Roberts C, Buckley DL, Parker GJ. Comparison of errors associated with single- and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. Magn Reson Med. 2006;56:611–619. doi: 10.1002/mrm.20971. [DOI] [PubMed] [Google Scholar]